Dual orexin receptor antagonism with lemborexant enhances microglial clearance of β-amyloid in mice.
Overview
- Department of Neurology, Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO USA
- Eisai Co., Ltd., Tsukuba, Ibaraki Japan
- Laboratory of System Neuroimmunology, Institute for Immunology at Tsinghua, IDG/McGovern Institute for Brain Research at Tsinghua, School of Basic Medical Sciences, Tsinghua Medicine, Tsinghua University, Beijing, China
- Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO USA
- School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong, China
- Department of Physiology, Department of Neuroscience, Sanders Brown Center on Aging, University of Kentucky, Lexington, KY USA
- Eisai Inc., Nutley, NJ USA
Abstract
Background: Sleep disturbances elevate brain amyloid-beta (Aβ) levels and represent a modifiable risk factor for Alzheimer’s disease (AD). The orexin/
Methods: PSAPP mice received lemborexant (10 or 30 mg/
Results: Lemborexant enhanced sleep quality with less active-phase sedation than doxepin. Both drugs reduced initial diffuse plaque deposition, but only lemborexant prevented fibrillar plaque accumulation in young mice and slowed plaque growth in older mice. Lemborexant increased peri-plaque microglial CD68 expression and enhanced Aβ phagocytosis in vivo. Single-cell transcriptomics revealed a shift toward activated, DAM-like microglial states with upregulation of phagocytic genes without broad inflammatory induction. Microglial depletion abolished lemborexant’s anti-amyloid effects.
Conclusions: Lemborexant mitigates amyloid pathology by augmenting microglial phagocytic function, positioning DORAs as promising therapeutics that couple sleep promotion with beneficial microglial modulation.
Supplementary information: The online version contains supplementary material available at 10.1186/
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper links to its data and to no code of its authors: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Datasets cited
- geo:GSE312840, at NCBI GEO; found in “Data availability”
Data availability
The scRNAseq dataset is freely available on the NIH GEO website under accession number GSE312840 (https://
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 28 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 15 authors, 5 keywords, 13 MeSH terms, 1 funder, 90 references.
Cite
This paper
Sharma, A., Segawa, E., Chen, X., Park, S., Wang, S., Irmen, R. E., Constantino, N. J., Wang, C., Kanan, M. F., Colonna, M., Macauley, S. L., Cheng, J. Y., Hatanaka, K., Moline, M., & Musiek, E. S. (2026). Dual orexin receptor antagonism with lemborexant enhances microglial clearance of β-amyloid in mice. Molecular neurodegeneration, 21(1), 28. https://
BibTeX
@article{sharma2026dual,
author = {Sharma, Ashish and Segawa, Emiko and Chen, Xiaoying and Park, Sohui and Wang, Shoutang and Irmen, Riley E and Constantino, Nicholas J and Wang, Chanung and Kanan, Michael F and Colonna, Marco and Macauley, Shannon L and Cheng, Jocelyn Y and Hatanaka, Ken and Moline, Margaret and Musiek, Erik S},
title = {{Dual orexin receptor antagonism with lemborexant enhances microglial clearance of β-amyloid in mice}},
journal = {Molecular neurodegeneration},
year = {2026},
month = may,
volume = {21},
number = {1},
pages = {28},
publisher = {BMC},
issn = {1750-1326},
doi = {10.1186/
url = {https://
pmid = {42174655},
pmcid = {PMC13214429}
}
RIS
TY - JOUR
AU - Sharma, Ashish
AU - Segawa, Emiko
AU - Chen, Xiaoying
AU - Park, Sohui
AU - Wang, Shoutang
AU - Irmen, Riley E
AU - Constantino, Nicholas J
AU - Wang, Chanung
AU - Kanan, Michael F
AU - Colonna, Marco
AU - Macauley, Shannon L
AU - Cheng, Jocelyn Y
AU - Hatanaka, Ken
AU - Moline, Margaret
AU - Musiek, Erik S
TI - Dual orexin receptor antagonism with lemborexant enhances microglial clearance of β-amyloid in mice
T2 - Molecular neurodegeneration
J2 - Mol Neurodegener
PY - 2026
DA - 2026/
VL - 21
IS - 1
SP - 28
SN - 1750-1326
PB - BMC
DO - 10.1186/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1186/
"type": "article-journal",
"title": "Dual orexin receptor antagonism with lemborexant enhances microglial clearance of β-amyloid in mice",
"container-title": "Molecular neurodegeneration",
"author": [
{
"family": "Sharma",
"given": "Ashish"
},
{
"family": "Segawa",
"given": "Emiko"
},
{
"family": "Chen",
"given": "Xiaoying"
},
{
"family": "Park",
"given": "Sohui"
},
{
"family": "Wang",
"given": "Shoutang"
},
{
"family": "Irmen",
"given": "Riley E"
},
{
"family": "Constantino",
"given": "Nicholas J"
},
{
"family": "Wang",
"given": "Chanung"
},
{
"family": "Kanan",
"given": "Michael F"
},
{
"family": "Colonna",
"given": "Marco"
},
{
"family": "Macauley",
"given": "Shannon L"
},
{
"family": "Cheng",
"given": "Jocelyn Y"
},
{
"family": "Hatanaka",
"given": "Ken"
},
{
"family": "Moline",
"given": "Margaret"
},
{
"family": "Musiek",
"given": "Erik S"
}
],
"container-title-short":
"volume": "21",
"issue": "1",
"page": "28",
"DOI": "10.1186/
"PMID": "42174655",
"PMCID": "PMC13214429",
"ISSN": "1750-1326",
"publisher": "BMC",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
5,
22
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1186/s13024-022-00588-y
- TREM2 dependent and independent functions of microglia in Alzheimer's disease.Journal: Molecular neurodegenerationIn common: Alzheimer's / dementia, mouse, cellular / molecular, 12 references
- [2] doi:10.3389/fnagi.2021.759983
- Does Chronic Sleep Fragmentation Lead to Alzheimer's Disease in Young Wild-Type Mice?Journal: Frontiers in aging neuroscienceIn common: Alzheimer's / dementia, mouse, cellular / molecular, 10 references
- [3] doi:10.1016/j.celrep.2021.110268 [code]
- Disrupted neural correlates of anesthesia and sleep reveal early circuit dysfunctions in Alzheimer models.Journal: Cell reportsIn common: Alzheimer's / dementia, mouse, 9 references
- [4] doi:10.1172/jci.insight.162771
- Neuronal deletion of the circadian clock gene Bmal1 induces cell-autonomous dopaminergic neurodegeneration.Journal: JCI insightIn common: mouse, cellular / molecular, 1 reference, 2 authors
- [5] doi:10.7554/elife.78191 [code]
- Timely coupling of sleep spindles and slow waves linked to early amyloid-β burden and predicts memory decline.Journal: eLifeIn common: Alzheimer's / dementia, 8 references
- [6] doi:10.1038/s43587-025-00950-x
- REV-ERBα regulates brain NAD&
lt;sup& gt;+& lt;/ sup& gt; levels and tauopathy via an NFIL3-CD38 axis. Journal: Nature agingIn common: Alzheimer's / dementia, mouse, cellular / molecular, 2 authors - [7] doi:10.1186/s12974-025-03659-1
- Microglial interferon signaling and Aβ plaque pathology are enhanced in female 5xFAD Alzheimer's disease mice, independent of estrous cycle stage.Journal: Journal of neuroinflammationIn common: Alzheimer's / dementia, genetics / omics, mouse, 1 other category, 8 references
- [8] doi:10.1186/s41232-025-00383-4
- Unraveling the complex role of microglia in Alzheimer's disease: amyloid β metabolism and plaque formation.Journal: Inflammation and regenerationIn common: Alzheimer's / dementia, cellular / molecular, 8 references
- [9] doi:10.1186/s13024-025-00887-0
- MS4A6A/
Ms4a6d deficiency disrupts neuroprotective microglia functions and promotes inflammation in Alzheimer's disease model. Journal: Molecular neurodegenerationIn common: histology / microscopy, Alzheimer's / dementia, genetics / omics, 2 other categories, 7 references - [10] doi:10.1016/j.isci.2022.104987
- The glymphatic system: Current understanding and modeling.Journal: iScienceIn common: 8 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
